MLICM
VCYT icon

Metropolitan Life Insurance Company (MetLife)’s Veracyte VCYT Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,123
Closed -$91.4K – 2032
2024
Q1 		$91.4K Sell
4,123
-232
-5% -$5.66K ﹤0.01% 1096
2023
Q4 		$120K Hold
4,355
– – 0.01% 985
2023
Q3 		$97.2K Buy
4,355
+283
+7% +$7.28K 0.01% 1033
2023
Q2 		$104K Buy
+4,072
New +$98.7K 0.01% 1001
2023
Q1 		– Sell
-4,527
Closed -$107K – 2469
2022
Q4 		$107K Hold
4,527
– – ﹤0.01% 1013
2022
Q3 		$75.1K Hold
4,527
– – ﹤0.01% 1189
2022
Q2 		$90.1K Hold
4,527
– – ﹤0.01% 1113
2022
Q1 		$125K Sell
4,527
-13,393
-75% -$383K ﹤0.01% 1065
2021
Q4 		$738K Hold
17,920
– – 0.01% 1166
2021
Q3 		$832K Buy
+17,920
New +$782K 0.01% 1102
2021
Q2 		– Sell
-18,079
Closed -$972K – 2887
2021
Q1 		$972K Buy
18,079
+1,281
+8% +$73.8K 0.01% 942
2020
Q4 		$822K Buy
16,798
+231
+1% +$10.7K 0.01% 1021
2020
Q3 		$538K Buy
16,567
+979
+6% +$31.1K 0.01% 1166
2020
Q2 		$404K Buy
15,588
+72
+0.5% +$1.79K 0.01% 1368
2020
Q1 		$377K Hold
15,516
– – 0.01% 1220
2019
Q4 		$433K Hold
15,516
– – 0.01% 1418
2019
Q3 		$372K Buy
15,516
+4,972
+47% +$132K 0.01% 1472
2019
Q2 		$301K Hold
10,544
– – 0.01% 1617
2019
Q1 		$264K Hold
10,544
– – ﹤0.01% 1712
2018
Q4 		$133K Hold
10,544
– – ﹤0.01% 2095
2018
Q3 		$101K Buy
+10,544
New +$116K ﹤0.01% 2449

Other funds holding VCYT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s VCYT Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Veracyte (VCYT) in Q2 2024, closing a stake of 4,123 shares — an estimated $91.4K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in VCYT in Q3 2018 and held it in 21 quarters. The position peaked at $972K in Q1 2021. 240 funds tracked by Wall St. Rank hold VCYT as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Veracyte position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 4,123 Veracyte shares in Q2 2024, an estimated $91.4K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Veracyte in Q3 2018 and held it in 21 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Veracyte position peaked at $972K in Q1 2021.
  • 240 funds tracked by Wall St. Rank held Veracyte as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.